TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 6.8 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS

William Sandborn  1     Julian Panés  2     Geert D’Haens  3     Bruce E. Sands  4     Remo Panaccione  5     Siew Cheng Ng  6     Thomas V Jones     Nervin Lawendy     nicole kulisek     Rajiv Mundayat     Chinyu Su    
1 University of California San Diego,La Jolla,United States
2 Hospital Clínic de Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
3 Academic Medical Center,Amsterdam,Netherlands
4 Icahn School of Medicine at Mount Sinai,New York,United States
5 University of Calgary,Calgary,Canada
6 Center for Gut Microbiota Research, Department of Medicine and

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing